CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- EFFECT Other Notice of Effectiveness
- S-3/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Option exercise President and CEO acquired 92,113 shares (option exercise)
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- 4 Open-market sale President and CEO sold 100,000 shares at $7.04 ($704,470)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise President and CEO acquired 40 shares (option exercise)
Page 17 of 41 · 801 filings